Arenthon, France

Thierry Berney

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Thierry Berney

Introduction

Thierry Berney is a notable inventor based in Arenthon, France. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of five patents to his name, Berney's work has the potential to impact medical treatments significantly.

Latest Patents

Among his latest patents are innovations related to anti-TLR4 antibodies. These inventions focus on antibodies that specifically bind to Toll-like Receptor 4 (TLR-4). The methods of using these anti-TLR4 antibodies as therapeutics are aimed at preventing transplant rejection and prolonging the survival of transplanted biological material. His work in this area demonstrates a commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Thierry Berney has worked with prominent companies in the biotechnology sector. Notable among these are Novimmune SA and Nordmark Arzneimittel GmbH & Co. KG. His experience in these organizations has contributed to his expertise and innovation in the field.

Collaborations

Berney has collaborated with several professionals in his field, including Marie Kosco-Vilbois and Katrien De Graaf. These collaborations have likely enriched his research and development efforts, leading to the successful patents he holds today.

Conclusion

Thierry Berney's contributions to biotechnology through his patents on anti-TLR4 antibodies highlight his role as an influential inventor. His work not only showcases his innovative spirit but also holds promise for advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…